| #57 | GSK Consumer Nigeria Plc. |
|---|---|
| BSM Index | 45 |
| YoY | – |
| CEO | Kunle Oyelana |
| Year Founded (in Nigeria) | 1971 |
| Website | www.ng.gsk.com |
| Head Office | 1, Industrial Avenue, Mushin, Lagos |
| Nationality | United Kingdom |
| Customer Base | – |
| Number of Branches | – |
| Annual Turnover | – |
| Employees | 131 |
| Marketing Budget | – |
GlaxoSmithKline Plc (GSK), a research-based pharmaceutical and healthcare company is a member of the British multinational pharmaceutical company headquartered in Brentford, England.
The principal activities of the Company are manufacturing, marketing and distribution of consumer healthcare and pharmaceutical products.
GlaxoSmithKline Plc was formed in 2000 as a result of a merger between Glaxo Wellcome Plc and SmithKline Beecham Plc, although its history can be traced back much further than that to London’s Plough Court Pharmacy in the 1700s.
In March 2015, the global business completed a three-part transaction with Novartis which reshapes our business.
GlaxoSmithKline Consumer Nigeria Plc was incorporated in Nigeria in 1971 and commenced business on 1st July 1972, under the name Beecham Limited.
The Company was quoted on the Nigerian Stock Exchange in 1977. In 1982, in order to expand its operations in the country, an ultra-modern drinks factory was established in Agbara Industrial Estate, Ogun State, which has since been expanded to include facilities to manufacture Oral Healthcare (OHC) and Wellness products. This has undergone continuous improvement and updates to meet the ever-increasing demands of the consumers, in a fast changing business environment.
In September 2016, GSK Nigeria business officially closed a transaction for the divestment of a part of its business. The transaction involved the sellingf to Suntory Beverage & Food Ltd the GSK Drinks bottling and distribution business and other assets including the factory appropriated to and utilised for the Drinks Business. The business was formally handed over to the new owners on 1st October 2016.
One of the objectives of the divestment was to allow the Nigeria business to focus on the same consumer healthcare portfolio as the parent group.
Following this handover, the new GSK Consumer Healthcare Company (retained business) includes Wellness (OTC), Oral Healthcare and Nutrition categories. The retained brands include Sensodyne, Macleans, Panadol, Horlicks, Andrews Liver Salts, Voltaren, Otrivin and CAC 1000.
GSK Consumer Nigeria Plc continues to be listed on the Nigerian Stock Exchange (NSE).
